BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32713129)

  • 1. The one-stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non-severe haemophilia A: Superiority or non-inferiority?
    Schütte LM; Hodes LS; van Moort I; Stoof SCM; Leebeek FWG; Cnossen MH; de Maat MPM; Kruip MJHA
    Haemophilia; 2020 Sep; 26(5):916-922. PubMed ID: 32713129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin in haemophilia: The need for a standardised clinical response and individualised test regimen.
    Stoof SCM; Schütte LM; Leebeek FWG; Cnossen MH; Kruip MJHA
    Haemophilia; 2017 Nov; 23(6):861-867. PubMed ID: 28636264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Modelling to Predict FVIII:C Response to Desmopressin and Its Reproducibility in Nonsevere Haemophilia A Patients.
    Schütte LM; van Hest RM; Stoof SCM; Leebeek FWG; Cnossen MH; Kruip MJHA; Mathôt RAA
    Thromb Haemost; 2018 Apr; 118(4):621-629. PubMed ID: 29458233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
    Schütte LM; Cnossen MH; van Hest RM; Driessens MHE; Fijnvandraat K; Polinder S; Beckers EAM; Coppens M; Eikenboom J; Laros-van Gorkom BAP; Meijer K; Nieuwenhuizen L; Mauser-Bunschoten EP; Leebeek FWG; Mathôt RAA; Kruip MJHA
    BMJ Open; 2019 Apr; 9(4):e022719. PubMed ID: 31015264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A.
    Stoof SC; Sanders YV; Petrij F; Cnossen MH; de Maat MP; Leebeek FW; Kruip MJ
    Thromb Haemost; 2013 Mar; 109(3):440-9. PubMed ID: 23348756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peri-operative desmopressin combined with pharmacokinetic-guided factor VIII concentrate in non-severe haemophilia A patients.
    Romano LGR; Schütte LM; van Hest RM; Meijer K; Laros-van Gorkom BAP; Nieuwenhuizen L; Eikenboom J; Heubel-Moenen FCJI; Uitslager N; Coppens M; Fijnvandraat K; Driessens MHE; Polinder S; Cnossen MH; Leebeek FWG; Mathôt RAA; Kruip MJHA;
    Haemophilia; 2024 Mar; 30(2):355-366. PubMed ID: 38343113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.
    Trossaert M; Lienhart A; Nougier C; Fretigny M; Sigaud M; Meunier S; Fouassier M; Ternisien C; Negrier C; Dargaud Y
    Haemophilia; 2014 Jul; 20(4):550-8. PubMed ID: 24517184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin in non-severe haemophilia A: Test-response and clinical outcomes in a single Canadian centre review.
    Hews-Girard J; Rydz N; Lee A; Goodyear MD; Poon MC
    Haemophilia; 2018 Sep; 24(5):720-725. PubMed ID: 30004154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogenic assay for BAY 81-8973 potency assignment has no impact on clinical outcome or monitoring in patient samples.
    Kitchen S; Katterle Y; Beckmann H; Maas Enriquez M
    J Thromb Haemost; 2016 Jun; 14(6):1192-9. PubMed ID: 27002680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.
    Pavlova A; Delev D; Pezeshkpoor B; Müller J; Oldenburg J
    Thromb Haemost; 2014 May; 111(5):851-61. PubMed ID: 24452774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A.
    Rodgers SE; Duncan EM; Sobieraj-Teague M; Lloyd JV
    Int J Lab Hematol; 2009 Apr; 31(2):180-8. PubMed ID: 18190586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B.
    Kihlberg K; Strandberg K; Rosén S; Ljung R; Astermark J
    Haemophilia; 2017 Jul; 23(4):620-627. PubMed ID: 28440032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.
    Castaman G; Mancuso ME; Giacomelli SH; Tosetto A; Santagostino E; Mannucci PM; Rodeghiero F
    J Thromb Haemost; 2009 Nov; 7(11):1824-31. PubMed ID: 19719828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies.
    Pezeshkpoor B; Gazorpak M; Berkemeier AC; Singer H; Pavlova A; Biswas A; Oldenburg J
    Ann Hematol; 2019 Aug; 98(8):1855-1865. PubMed ID: 30997536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between the results of one-stage and chromogenic factor VIII: C assays in patients with mild/moderate hemophilia A.
    Vosough F; Ahmadinejad M; Toogeh G; Karimi K; Homayoun S; Managhchi MR; Arabkhazaeli A
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):530-535. PubMed ID: 33141777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
    Gilmore R; Harmon S; Gannon C; Byrne M; O'Donnell JS; Jenkins PV
    Haemophilia; 2010 Jul; 16(4):671-4. PubMed ID: 20148980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-stage vs. chromogenic assays in haemophilia A.
    Potgieter JJ; Damgaard M; Hillarp A
    Eur J Haematol; 2015 Feb; 94 Suppl 77():38-44. PubMed ID: 25560793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results.
    Rodgers SE; Duncan EM; Barbulescu DM; Quinn DM; Lloyd JV
    Br J Haematol; 2007 Jan; 136(1):138-45. PubMed ID: 17222201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDAVP challenge tests in boys with mild/moderate haemophilia A.
    Revel-Vilk S; Blanchette VS; Sparling C; Stain AM; Carcao MD
    Br J Haematol; 2002 Jun; 117(4):947-51. PubMed ID: 12060135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A.
    Novembrino C; Boscolo Anzoletti M; Mancuso ME; Shinohara S; Peyvandi F
    Haemophilia; 2019 May; 25(3):521-526. PubMed ID: 31044485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.